Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 5Venous Thromboembolism 2Prostatic Neoplasms 2Neoplasms 2Endometrial Neoplasms 2Cardiovascular Diseases 2Venous Thrombosis 1Stroke 1Rectal Neoplasms 1Pulmonary Embolism 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Neoplasm Metastasis 1Ischemic Attack, Transient 1Hypoalphalipoproteinemias 1Healthy Volunteers 1Endometrial Hyperplasia 1Cardiotoxicity 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Atherosclerosis 1

Interventions

Oxaliplatin 180Capecitabine 174Fluorouracil 154Radiotherapy 107Leucovorin 107Irinotecan 93Bevacizumab 69Surgical Procedures, Operative 49Cetuximab 39Drug Therapy 38Radiation 35Neoadjuvant Therapy 33Folfox protocol 29Chemoradiotherapy 29XELOX 22Magnetic Resonance Spectroscopy 21Chemotherapy, Adjuvant 21Radiotherapy, Intensity-Modulated 19Surveys and Questionnaires 17Proctectomy 16Biopsy 16Early Intervention, Educational 14trifluridine tipiracil drug combination 12Panitumumab 12Floxuridine 12tislelizumab 11regorafenib 11Nivolumab 11Laparoscopy 11Celecoxib 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Rectal Neoplasms × Rosuvastatin Calcium × Clear all
NCT02569645 2022-07-20

Rosuvastatin in the Treatment of Rectal Cancer

AHS Cancer Control Alberta

Phase 2 Completed
45 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡